Basel Medical Group Ltd Ordinary Shares (BMGL)vsFresenius Medical Care Corporation (FMS)
BMGL
Basel Medical Group Ltd Ordinary Shares
$0.54
+12.27%
HEALTHCARE · Cap: $12.32M
FMS
Fresenius Medical Care Corporation
$22.03
+0.46%
HEALTHCARE · Cap: $12.00B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 170384% more annual revenue ($19.36B vs $11.35M). FMS leads profitability with a 4.9% profit margin vs -93.7%. FMS earns a higher WallStSmart Score of 50/100 (C-).
BMGL
Avoid31
out of 100
Grade: F
FMS
Buy50
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BMGL.
Margin of Safety
+69.0%
Fair Value
$77.65
Current Price
$22.03
$55.62 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 27.3% year-over-year
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -248.7% — below average capital efficiency
Grey zone — moderate risk
ROE of 7.1% — below average capital efficiency
4.9% margin — thin
Revenue declined 5.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : BMGL
The strongest argument for BMGL centers on Price/Book, Revenue Growth. Revenue growth of 27.3% demonstrates continued momentum.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.
Bear Case : BMGL
The primary concerns for BMGL are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : FMS
The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.
Key Dynamics to Monitor
BMGL profiles as a growth stock while FMS is a value play — different risk/reward profiles.
BMGL is growing revenue faster at 27.3% — sustainability is the question.
FMS generates stronger free cash flow (37M), providing more financial flexibility.
Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
FMS scores higher overall (50/100 vs 31/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Basel Medical Group Ltd Ordinary Shares
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Basel Medical Group Ltd provides healthcare services. The company is headquartered in Singapore.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?